title: Impact of Omalizumab on Poor Asthma Control Events and Medication Utilisation in Patients With Moderate or Severe Persistent Asthma.
authors.affiliation: Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
authors.forename: T C
authors.initials: TC
authors.lastname: Yu
authors.affiliation: Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
authors.forename: T
authors.initials: T
authors.lastname: Nazareth
authors.affiliation: Novartis Pharmaceuticals, East Hanover, NJ, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Turner
authors.affiliation: Genentech Inc., South San Francisco, CA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Raimundo
authors.affiliation: KMK Consulting Inc., Florham Park, NJ, USA.
authors.forename: H
authors.initials: H
authors.lastname: Zhou
authors.affiliation: Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
authors.forename: B
authors.initials: B
authors.lastname: Ortiz
authors.affiliation: Career International Inc., Shanghai, China.
authors.forename: L
authors.initials: L
authors.lastname: Li